SNY logo

Sanofi (SNY)

Profile

Full Name

Sanofi

Ticker Symbol

SNY

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

France

IPO

July 1, 2002

Indexes

Not included

Website

http://www.sanofi.com

Employees

82878

Key Details

Price

$51.50(+3.71%)

Market cap

$129.12B(Mega cap)

Last Dividend

$2.04

TTM Dividend yield

3.96%

Annual revenue

$47.93B(+6.39% YoY)

Annual EPS

$2.40(+3.00% YoY)

PE ratio

20.61

Next earnings date

Apr 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$51.50
SNY price is $51.50

30-Day Relative Volume

0.81
SNY 30-day relative volume is 0.81

Price Performance

Price Most recent change

+3.71%
SNY price was up +3.71% on Apr 11, 2025

Price YTD change

+6.78%
SNY price is up +6.78% since January 1st

Price 1-year change

+10.52%
SNY price is up +10.52% year-on-year

Price 3-year change

-10.37%
SNY price is down -10.37% over the past 3 years

Price Range

Price All-time high

$60.12
SNY price is currently -14.34% below its historical high of $60.12

Price 3-year low

$36.91
SNY price is currently +39.53% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$129.12B
SNY market capitalization is $129.12 billion

Market cap 3-year change

-10.02%
SNY market capitalization is down -10.02% over the past 3 years

Market cap All-time high

$151.34B
SNY market capitalization is currently -14.68% below its historical high of $151.34 billion

Market cap sector rank

98.77%
SNY market capitalization is higher than 98.77% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.43%
SNY shares outstanding is up +0.43% year-on-year

Shares Outstanding 3-Year Change

+0.4%
SNY shares outstanding is up +0.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.21
SNY beta is 0.21

200-day SMA

$52.85
SNY price is currently -2.55% below its 200-day simple moving average

50-day SMA

$55.08
SNY price is currently -6.50% below its 50-day simple moving average

RSI

40.17
SNY 14-day relative strength index is 40.17

Volume

0.81
SNY 30-day relative volume is 0.81

ATR

$1.76
SNY average true range is $1.76

10-day Historical Volatility

41.96%
SNY 10-day historical volatility is 41.96%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$2.04
SNY last dividend was $2.04 per share, with an ex-dividend date of May 9, 2024

Next Dividend

-
SNY next dividend has not yet been announced

Dividend per share

Dividend per share

$2.04
SNY annual dividend per share is $2.04

Dividend per share Sector Rank

72.09%
SNY annual dividend per share is higher than 72.09% of companies in Healthcare sector

Dividend per share 1-Year Change

+7.2%
SNY annual dividend per share is up +7.2% year-on-year

Dividend per share 3-Year Change

+5.6%
SNY annual dividend per share is up +5.6% over the past 3 years

Dividend yield

Dividend yield

3.96%
SNY annual dividend yield is 3.96%

Dividend yield Sector Rank

75.29%
SNY annual dividend yield is higher than 75.29% of companies in Healthcare sector

Other

Payout ratio

84.60%
SNY annual payout ratio is 84.60%

Dividends paid

$5.09B
SNY annual dividends paid is $5.09 billion

Free cash flow

$6.37B
SNY annual free cash flow is $6.37 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$47.93B
SNY annual revenue is $47.93 billion

Revenue Analysts estimate

$46.56B
SNY annual revenue is currently +2.96% higher than the consensus analysts' forecast

Revenue 1-year change

+6.39%
SNY annual revenue is up +6.39% year-on-year

Revenue Sector rank

97.98%
SNY annual revenue is higher than 97.98% of companies in Healthcare sector

EPS

EPS

$2.40
SNY annual earnings per share is $2.40

EPS Analysts estimate

$4.51
SNY annual earnings per share is currently -46.81% lower than the consensus analysts' forecast

EPS 1-year change

+3%
SNY annual earnings per share is up +3% year-on-year

EPS Sector rank

93.06%
SNY annual earnings per share is higher than 93.06% of companies in Healthcare sector

Profit

Gross profit

$33.64B
SNY annual gross profit is $33.64 billion

Gross margin

70.18%
SNY annual gross profit margin is 70.18%

Operating profit

$10.24B
SNY annual operating income is $10.24 billion

Operating margin

21.37%
SNY annual operating profit margin is 21.37%

Net income

$6.02B
SNY annual net profit is $6.02 billion

Net margin

12.97%
SNY annual net profit margin is 12.97%

Expenses

Total expenses

$37.69B
SNY annual total expenses is $37.69 billion

Operating expenses

$23.40B
SNY annual total operating expenses is $23.40 billion

Cost of goods sold

$14.29B
SNY annual cost of goods sold is $14.29 billion

Selling, general & administrative expenses

$9.94B
SNY annual SGA is $9.94 billion

Depreciation and amortization

$3.88B
SNY annual depreciation & amortization is $3.88 billion

Interest expense

$810.68M
SNY annual interest expense is $810.68 million

Income tax

$1.36B
SNY annual income tax is $1.36 billion

EBIT & EBITDA

EBIT

$8.67B
SNY annual earnings before interest & taxes is $8.67 billion

EBITDA

$10.56B
SNY annual EBITDA is $10.56 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$138.19B
SNY annual total assets is $138.19 billion

Non current assets

$94.06B
SNY annual long term assets is $94.06 billion

Current assets

$44.31B
SNY annual total current assets is $44.31 billion

Cash and cash equivalents

$7.74B
SNY annual cash & cash equivalents is $7.74 billion

Accounts receivable

$7.99B
SNY annual accounts receivable is $7.99 billion

Inventory

$21.78B
SNY annual inventory is $21.78 billion

Liabilities

Total liabilities

$57.17B
SNY annual total liabilities is $57.17 billion

Long term liabilities

$26.82B
SNY annual total long term liabilities is $26.82 billion

Current liabilities

$30.34B
SNY annual total current liabilities is $30.34 billion

Accounts payable

$22.68B
SNY annual accounts payable is $22.68 billion

Debt

Total debt

$18.63B
SNY annual total debt is $18.63 billion

Total debt 1-year change

-8.5%
SNY annual total debt is down -8.5% year-on-year

Long term debt

$13.98B
SNY annual long term debt is $13.98 billion

Short term debt

$4.65B
SNY annual short term debt is $4.65 billion

Equity & Capital

Shareholders equity

$80.65B
SNY annual stockholders equity is $80.65 billion

Book value

$80.84B
SNY annual book value is $80.84 billion

Retained earnings

-
SNY annual retained earnings value is unknown

Working capital

$13.97B
SNY annual working capital is $13.97 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$9.83B
SNY annual cash flow from operations is $9.83 billion

Cash from operations 1-year change

-11.5%
SNY annual cash flow from operations is down -11.5% year-on-year

Cash from investing

-$4.77B
SNY annual cash flow from investing activities is -$4.77 billion

Cash from investing 1-year change

+28.94%
SNY annual cash flow from investing activities is up +28.94% year-on-year

Cash from financing

-$6.24B
SNY annual cash flow from financing activities is -$6.24 billion

Cash from financing 1-year change

+28.44%
SNY annual cash flow from financing activities is up +28.44% year-on-year

CAPEX

CAPEX

$3.46B
SNY annual capital expenditures is $3.46 billion

CAPEX 1-year change

+9.92%
SNY annual capital expenditures is up +9.92% year-on-year

Free Cash Flow

Free cash flow

$6.37B
SNY annual free cash flow is $6.37 billion

Free cash flow 1-year change

-19.96%
SNY annual free cash flow is down -19.96% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

70.18%
SNY annual gross profit margin is 70.18%

Operating margin

21.37%
SNY annual operating profit margin is 21.37%

Net margin

12.97%
SNY annual net profit margin is 12.97%

ROA & ROE

ROA

4.33%
SNY annual return on assets is 4.33%

ROE

7.37%
SNY annual return on equity is 7.37%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

20.61
SNY price to earnings ratio is 20.61

PE ratio Sector rank

41.18%
SNY price to earnings ratio is higher than 41.18% of companies in Healthcare sector

PB Ratio

PB ratio

1.60
SNY price to book ratio is 1.60

PB ratio Sector rank

57.32%
SNY price to book ratio is higher than 57.32% of companies in Healthcare sector

PS Ratio

PS ratio

2.69
SNY price to sales ratio is 2.69

PS ratio Sector rank

49.87%
SNY price to sales ratio is higher than 49.87% of companies in Healthcare sector

Enterprise value

Enterprise value

$140.01B
SNY enterprise value is $140.01 billion

Enterprise value Sector rank

98.52%
SNY enterprise value is higher than 98.52% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

12.66
SNY EV/EBITDA is 12.66

EV/EBITDA Sector rank

85.68%
SNY EV/EBITDA is higher than 85.68% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.46
SNY annual current ratio is 1.46

Quick ratio

0.74
SNY annual quick ratio is 0.74

Leverage

Debt to equity

0.21
SNY annual debt to equity ratio is 0.21

Interest coverage ratio

10.69
SNY annual interest coverage ratio is 10.69

Risk & Stability

Piotroski F-Score

-
SNY piotroski f-score value is unknown

Altman Z-Score

-
SNY altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 21, 25 Goldman Sachs
Neutral
Jul 26, 24 Argus Research
Buy
Jan 23, 24 Morgan Stanley
Equal-Weight
Mar 27, 23 Argus Research
Buy
Aug 12, 22 Deutsche Bank
Hold
Sep 27, 21 SVB Leerink
Outperform
Jan 15, 21 Deutsche Bank
Sell
Mar 11, 20 Goldman Sachs
Buy
Feb 19, 20 Argus Research
Buy
Feb 11, 20 SVB Leerink
Market Perform

Institutional Ownership

Similar stocks

GILD logo
Gilead Sciences (GILD)
SYK logo
Stryker (SYK)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
PFE logo
Pfizer (PFE)
DHR logo
Danaher (DHR)
BSX logo
Boston Scientific (BSX)
MDT logo
Medtronic (MDT)
AMGN logo
Amgen (AMGN)
BMY logo
Bristol-Myers Squibb (BMY)
  • What is the ticker symbol for Sanofi?
  • Does Sanofi pay dividends?
  • What sector is Sanofi in?
  • What industry is Sanofi in?
  • What country is Sanofi based in?
  • When did Sanofi go public?
  • Is Sanofi in the S&P 500?
  • Is Sanofi in the NASDAQ 100?
  • Is Sanofi in the Dow Jones?
  • When was Sanofi's last earnings report?
  • When does Sanofi report earnings?

What is the ticker symbol for Sanofi?

The ticker symbol for Sanofi is NASDAQ:SNY

Does Sanofi pay dividends?

Yes, Sanofi pays dividends. The last payment was $2.04, with an ex-dividend date on May 9, 2024

What sector is Sanofi in?

Sanofi is in the Healthcare sector

What industry is Sanofi in?

Sanofi is in the Drug Manufacturers - General industry

What country is Sanofi based in?

Sanofi is headquartered in France

When did Sanofi go public?

Sanofi's initial public offering (IPO) was on July 1, 2002

Is Sanofi in the S&P 500?

No, Sanofi is not included in the S&P 500 index

Is Sanofi in the NASDAQ 100?

No, Sanofi is not included in the NASDAQ 100 index

Is Sanofi in the Dow Jones?

No, Sanofi is not included in the Dow Jones index

When was Sanofi's last earnings report?

Sanofi's most recent earnings report was on Jan 30, 2025

When does Sanofi report earnings?

The next expected earnings date for Sanofi is Apr 24, 2025
On this page